Biomedical Science and Research
by Jenna Ogilvie | Jan 15, 2015 | Discussion Paper, Perspectives
The types of evidence needed to support the use of genome sequencing in the clinic varies by stakeholder and circumstance. In this IOM series, seven individually authored commentaries explore this important issue, discussing the challenges involved in and...
by Jenna Ogilvie | Sep 2, 2014 | Discussion Paper, Perspectives
In our leadership roles with Academic Health Systems, we are simultaneously excited by the stunning potential we see for health and health care and also sensitive to the strains that arise from the pace of changes underway in the organization, financing, and...
by Jenna Ogilvie | May 9, 2013 | Discussion Paper, Perspectives
The public health laboratory (PHL) system in the United States is composed of a web of local, state, and federal facilities that provide a broad scope and level of services. Supporting the workforce of the PHL network is particularly challenging due to the impact of...
by Jenna Ogilvie | Apr 23, 2013 | Discussion Paper, Perspectives
Rising health care costs continue to stress budgets at all levels—family, employer, state, and national. At the same time, the results from health care are not commensurate with this level of investment. But there is cause for optimism that results can improve: the...
by Laura DeStefano | Mar 22, 2013 | Commentary, Perspectives
Support for core public health capacity is diminishing; outbreaks of microbial threats are not. In 2012 there were a number of high-profile threats (see the box below) that demanded public health intervention to protect the public. It is well understood that the role...
by Laura DeStefano | Mar 15, 2013 | Commentary, Perspectives
In October 2007, HSPD 21 called for a nationwide biosurveillance capability. Biosurveillance “in the context of human health is the science and practice of managing health-related data and information for early warning of threats and hazards, early detection of...
by Jenna Ogilvie | Jan 16, 2013 | Discussion Paper, Perspectives
Executive Summary In response to issues raised in the report of the World Health Organization (WHO)-affiliated Consultative Expert Working Group (CEWG) on research and development (R&D) financing and coordination and the desire of the U.S. government to obtain a...
by Laura DeStefano | Nov 2, 2012 | Commentary, Perspectives
The translation of new evidence into reliable practice typically takes years and sometimes decades. For interventions with a strong evidence base for improving outcomes, the absence of a reliable evidence implementation capacity means that the health system regularly...
by Laura DeStefano | Oct 19, 2012 | Commentary, Perspectives
Diabetes mellitus (DM) and associated complications are increasing in the United States, with prevalence up 40 percent from 2002 to 2010. [1] Randomized controlled studies have shown reductions in the increased cardiovascular disease risk associated with diabetes when...
by Laura DeStefano | Oct 5, 2012 | Commentary, Perspectives
My story of innovation begins in 1981, when, as a young surgical trainee in Boston, I was shocked to learn that my dreams of joining the pioneers in the exciting new field of heart transplantation had been abruptly shattered—by a policy decision. The trustees of the...
Page 7 of 8« First«...45678»
